Bernstein analyst Callum Elliott lowered the firm’s price target on Procter & Gamble to $153 from $162 and keeps a Market Perform rating on the shares. Over the past few months, the relative premium of staples versus the market has “rapidly unwound,” the analyst tells investors in a research note. As such, the firm thinks the risk/reward for the group looks less negative than it has over most of the past few years.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PG: